Heavy-weight contender COVID-19 landed some brutal blows to revenue in Q220, but companies look for better days in the second half of 2020.
Among the many topics covered in the comprehensive Q220 US Joint Fluid Replacement Market Recap* are:
- Complete Market Overview with Company Revenues and Shares
- HA Market Segment Recap
- Shifts in Market Share Among Major Companies
- Other Notable Developments in Q220
- Looking Ahead
It is also anticipated that hospitals will continue to face special challenges with the influx of COVID-19 patients, and levels of elective procedures in the hospital and possibly ASC and office settings continuing to be depressed, especially as COVID-19 hotspots emerge in different geographies. So, with virus cases resurfacing across the South and Midwest leading to renewed limits on certain business activities, and the possibility of the flu season dealing a double-blow to the healthcare system and the economy, fear of a W-shaped recovery is increasingly ...
*The entire article and the links can only be viewed by SmartTRAK subscribers to this module. For more information on how to receive a demo and subscribe, please click the button below.
